Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some anti-depressants and hallucinogens.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D003984:Dibenzazepines / Q000494:pharmacology; D004338:Drug Combinations; D006213:Hallucinogens / Q000494:pharmacology*; D006614:Hindlimb / Q000187:drug effects; D006651:Histocytochemistry; D007700:Kinetics; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008856:Microscopy, Fluorescence; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D011562:Psilocybin / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012018:Reflex / Q000187:drug effects; D012701:Serotonin / Q000096:biosynthesis*; D013116:Spinal Cord / Q000378:metabolism*; D013696:Temperature; D014363:Tryptamines / Q000494:pharmacology
D000928:Antidepressive Agents; D003984:Dibenzazepines; D004338:Drug Combinations; D006213:Hallucinogens; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D011562:Psilocybin; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D010293:Pargyline; D000661:Amphetamine; D009526:Nialamide